IBM20240725
2024-07-25 16:43
Welcome and thank you for standing by. At this time, all participants are in a listen-only mode. Today's conference is being recorded. If you have any objections, you may disconnect at this time. Now, I will turn the meeting over to Olympia McNerney, IBM's Global Head of Investor Relations. Olympia, you may begin. Thank you. I'd like to welcome you to IBM's second quarter 2024 earnings presentation. I'm Olympia McNerney, and I'm here today with Arvind Krishna, IBM's Chairman and Chief Executive Officer, and ...
Clearside Biomedical, Inc. (CLSD) Suprachoroidal Space Drug Delivery (Transcript)
2024-07-25 03:23
Clearside Biomedical, Inc. (NASDAQ:CLSD) Suprachoroidal Space Drug Delivery Call July 24, 2024 8:00 AM ET Company Participants Jenny Kobin - Investor Relations George Lasezkay - President and Chief Executive Officer Glenn Yiu - Scientific Advisory Board Victor Chong - Chief Medical Officer David Brown - Director of Research, Retina Consultants Houston Conference Call Participants Annabel Samimy - Stifel Andreas Argyrides - Oppenheimer & Co. Serge Belanger - Needham & Company Yi Chen - H.C. Wainwright Operat ...
Cellectar Biosciences, Inc. (CLRB) KOL and Analyst Day Call Transcript
2024-07-24 19:22
Cellectar Biosciences, Inc. (NASDAQ:CLRB) KOL and Analyst Day Call July 24, 2024 8:00 AM ET Company Participants James Caruso - President and Chief Executive Officer Sikander Ailawadhi - Professor of Medicine at Mayo Clinic Michael Morris - Co-Founder of United Theranostics and the Medical Director of Advanced Molecular Imaging and Therapy and United Theranostic Centers of Excellence Jarrod Longcor - Chief Operating Officer Conference Call Participants Edward Tenthoff - Piper Sandler Jeff Jones - Oppenheim ...
Jaguar Health, Inc. (JAGX) Special Call Transcript
2024-07-23 18:09
Jaguar Health, Inc. (NASDAQ:JAGX) Special Conference Call July 23, 2024 8:30 AM ET Company Participants Lisa Conte - Founder, President & Chief Executive Officer Pravin Chaturvedi - Chief Scientific Officer & Chairman of Scientific Advisory Board Stacey Tinianov - Member of Napo's Scientific Advisory Board Allison Ackerman Shrier - Vice President of Medical Affairs & Clinical Research at Napo Pharmaceuticals Conference Call Participants Operator [Call starts abruptly] Before I turn the call over to manageme ...
Owens & Minor, Inc. (OMI) Special Conference Call (Transcript)
2024-07-23 14:52
Owens & Minor, Inc. (NYSE:OMI) Special Conference Call July 23, 2024 8:30 AM ET Company Participants Jacqueline Marcus - Investor Relations, Alpha IR Group Edward Pesicka - President and Chief Executive Office Jonathan A. Leon - Interim CFO and SVP of Finance and Corporate Treasurer Conference Call Participants Stephanie Davis - Barclays John Stansel - JP Morgan Daniel Clark - Leerink Partners Allen Lutz - Bank of America Operator Greetings, welcome to Owens & Minor Special Conference Call to discuss its p ...
Ionis Pharmaceuticals, Inc. (IONS) HALOS Study of ION582 in Angelman Syndrome - (Transcript)
2024-07-22 17:15
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) HALOS Study of ION582 in Angelman Syndrome Conference Call July 22, 2024 8:00 AM ET Company Participants Wade Walke - Senior Vice President of Investor Relations Brett Monia - Chief Executive Officer Holly Kordasiewicz - Senior Vice President, Neurology Elizabeth Jalazo - Assistant Professor of Pediatrics, Division of Genetics & Metabolism, University of North Carolina School of Medicine Becky Crean - Executive Director, Neurology Lynne Bird - Professor of Clinical ...
Opendoor key takeaway at JP rgan T nference
conversica· 2024-07-22 14:57
# Current State of the Housing Market. Sellers are locked in due to mortgage rates, which limits supply, and buyers face affordability issues, again due to mortgage rates. Therefore, transactions are depressed. However, what matters most to OPEN is home price stability, and mgmt is seeing home price stability. Overall, mgmt doesn t see a significant change in the supply-demand dynamic relative to 2023. Importantly, mgmt believes there is pent-up demand that will come back with rate relief, and OPEN is maint ...
US ekly Kickart_ Whipla! Epic moment reversal will persi unless mega cap Tech ises forward revenue guidance
umwelt bundesamt· 2024-07-21 04:06
20\REPOST-USKickstart\Kickstart2020-11- 20T22_44_20Z2020-11-20T23_19_23Z.pptx byercr\home\Desktop\BCB_0-SA_MAIN\BCB_2020-NOV- 19 July 2024 | 4:50PM EDT d167510246fd4ce99a1e32310e9ef8de US Weekly Kickstart Whiplash! Epic momentum reversal will persist unless mega cap Tech raises forward revenue guidance Small-caps just posted the most powerful weekly return vs. large-caps on record. Against a backdrop of extreme equity market concentration, four factors explain the reversal: (1) Decelerating inflation and in ...
Westwater Resources Inc. (WWR) Business Update Conference Call Transcript
2024-07-19 16:15
Westwater Resources Inc. (NYSE:WWR) Business Update Conference Call July 18, 2024 10:00 AM ET Company Participants Frank Bakker - President and CEO Steve Cates - CFO Terence Cryan - Executive Chairman Conference Call Participants Operator Thank you for standing by. This is the conference operator. Welcome to the Westwater Resources Inc., Business Update and Investor Call. As a reminder, all participants are in listen-only mode. The conference is being recorded. [Operator Instructions]. I would now like to t ...
FB Fancial rpotion
ray dalio· 2024-07-18 12:48
Good morning, and welcome to the FB Financial Corporation's second quarter 2024 earnings conference call. Hosting the call today from FB Financial are Mr. Chris Holmes, President and Chief Executive Officer, and Mr. Michael Matee, Chief Financial Officer. Also joining the call for the question and answer session is Mr. Travis Edmondson, Chief Banking Officer. Please note, FB Financial's earnings release Supplemental financial information in this morning's presentation are available on the Investor Relations ...